<SEC-DOCUMENT>0001140361-21-019245.txt : 20210528
<SEC-HEADER>0001140361-21-019245.hdr.sgml : 20210528
<ACCEPTANCE-DATETIME>20210528161705
ACCESSION NUMBER:		0001140361-21-019245
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210430
FILED AS OF DATE:		20210528
DATE AS OF CHANGE:		20210528

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Persofsky Renah
		CENTRAL INDEX KEY:			0001835209

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38594
		FILM NUMBER:		21980422

	MAIL ADDRESS:	
		STREET 1:		55 PRINCE ARTHUR AVENUE
		STREET 2:		#604
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5R 1B3

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tilray, Inc.
		CENTRAL INDEX KEY:			0001731348
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				824310622
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		745 FIFTH AVENUE
		STREET 2:		SUITE 1602
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10151
		BUSINESS PHONE:		519.322.8800

	MAIL ADDRESS:	
		STREET 1:		745 FIFTH AVENUE
		STREET 2:		SUITE 1602
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10151
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>FORM 4/A
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2021-04-30</periodOfReport>

    <dateOfOriginalSubmission>2021-05-04</dateOfOriginalSubmission>

    <issuer>
        <issuerCik>0001731348</issuerCik>
        <issuerName>Tilray, Inc.</issuerName>
        <issuerTradingSymbol>TLRY</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001835209</rptOwnerCik>
            <rptOwnerName>Persofsky Renah</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O TILRAY, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>745 FIFTH AVENUE, SUITE 1602</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10151</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Class 2 Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2021-04-30</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>15639</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>15639</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Received in exchange for 18,662 common shares of Aphria Inc. (&quot;Aphria&quot;) in connection with the plan of arrangement (the &quot;Arrangement&quot;) between Tilray, Inc. (&quot;Tilray&quot;) and Aphria, pursuant to which each common share of Aphria was exchanged for 0.8381 of a share of Class 2 common stock, par value $0.0001 per share, of Tilray (&quot;Tilray Class 2 Common Stock&quot;). On the effective date of the Arrangement, the closing price of Aphria's common shares was $15.38 per common share, and the closing price of Tilray's Class 2 Common Stock was $18.34 per share. The Form 4 filed on May 4, 2021 inadvertently omitted the amount of shares of Tilray Class 2 Common Stock acquired by the reporting person in connection with the Arrangement.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Carl A. Merton, as Attorney-In-Fact for Renah Persofsky</signatureName>
        <signatureDate>2021-05-28</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
